The obtained results point to an association between activated ERK1/2 and cytoplasmic localization of NR4A1 and indicate that ERK1/2 signalling may play a role in cytoplasmic localization of NR4A1 in aggressive lymphomas. Here, MAPK3 is linked to lymphoma.